A double-digit discount would signal investors are demanding a sizeable concession to fund Oracle’s AI buildout, adding to pressure on the stock after a sharp slide since last week’s investor day. For the wider AI trade, it reinforces a growing split between cash-rich hyperscalers that can self-fund and companies such as Oracle and the neoclouds that need outside capital. Demand for the parallel $10 billion bond deal, and where it prices relative to Oracle’s existing debt, will be a key gauge of credit market appetite for AI-linked borrowers. Once the deal prices, the removal of supply overhang could steady the shares if the discount proves to be a clearing level rather than a sign of weak demand.
–
Earlier:
–
Oracle is paying up to raise equity for its AI buildout, with a reported 11% discount underlining how much harder it is to fund the spending race without a hyperscaler’s balance sheet.
Summary:
- Oracle is poised to price its $10 billion share sale at an 11% discount, according to reports; it is not yet clear which share price the discount is measured against
- The stock sale runs alongside a separate $10 billion bond offering in six tranches maturing between 2029 and 2046; neither deal depends on the other
- The combined $20 billion uses up the full funding cap Oracle set at its investor day last week, split evenly between equity and debt
- At Friday’s close of about $131, the sale implied about 77 million new shares, roughly 2.5% dilution; a discount means more shares and slightly higher dilution
- Oracle shares fell about 6% to 7% on Monday, and the company has lost nearly $65 billion in market value since last Wednesday
- Proceeds are earmarked for general corporate purposes, which can include capital spending and debt repayment
Oracle is poised to price a $10 billion sale of new shares at an 11% discount, according to reports. The move underlines the cost of raising capital for its artificial intelligence buildout. It was not immediately clear whether the discount is measured against Friday’s closing price or Monday’s lower close, which would change the size of the concession and the number of shares issued.
The equity sale is one of two offerings Oracle filed on Monday, alongside a separate $10 billion sale of senior notes across six tranches with maturities from 2029 to 2046. The deals are independent of each other. Oracle said the proceeds would be used for general corporate purposes, which may include capital expenditure, debt repayment, acquisitions, dividends and share buybacks. Morgan Stanley and Goldman Sachs are among the bookrunners on the stock sale.
The timing has unsettled investors. At its investor day last Wednesday, Oracle pledged to limit new capital-market funding for its fiscal 2027 to 2030 investment cycle to $20 billion, split evenly between equity and debt, and the shares rallied 12% the next day. Five days later it moved to raise the entire amount.
Based on Friday’s closing price of about $131, the stock sale implied roughly 77 million new shares, lifting the share count to about 3.1 billion and diluting existing holders by around 2.5%. Pricing at a discount would require more shares to raise the same sum. The bond sale would add about 8% to Oracle’s total debt of around $125 billion.
Oracle shares fell about 6% to 7% on Monday, extending a slide that has wiped nearly $65 billion off its market value since Wednesday. The company has reaffirmed fiscal 2027 guidance for at least $90 billion in revenue and $8.10 in adjusted earnings per share.
The deal highlights a widening divide in how the AI buildout is financed. In its latest shareholder letter, Pershing Square argued that the funding needs of Oracle and the neoclouds should not be confused with those of the largest hyperscalers, which it said can largely fund their spending from operating cash flow. Final pricing of both offerings, and demand for the bonds in particular, will show how much investors are willing to commit to Oracle’s side of that divide.
This article was written by Eamonn Sheridan at investinglive.com.